Industry & Business

BioMarin expands facility to manufacture medicine for rare genetic diseases

 Breaking News
  • New ‘Erasmus Student Network’ booking platform launched at Ryanair Ryanair has launched a new dedicated booking platform in partnership with Erasmus Student Network, offering Erasmus students fare discounts, free bags and tailored travel offers. Delivered as part of Year 4 of Ryanair’s “Always Getting Better” programme, this partnership offers Erasmus students a dedicated ESN booking platform where they can avail of: 15% flight discounts on the [...]...
  • Thermo King manufacturing facility in Galway with zero waste to landfill The Galway manufacturing facility of Thermo King, a manufacturer of transport temperature control solutions for a variety of mobile applications and a brand of Ingersoll Rand, has become one of the first Ingersoll Rand sites to manage zero waste to landfill. The sustainability push in the Thermo King Galway factory builds on the Ingersoll Rand Climate Commitment made [...]...
  • Irish SME develops app to help students connect with colleges Irish start-up StudyBundles has developed an app that helps CAO applicants connect with third-level institutions while they are deciding which college to attend. The CampusConnect app benefits students as they become immersed in college life before they step foot on campus, making the transition easier. For colleges and universities it helps them to convert student [...]...
  • Lack and cost of accommodation biggest problem for tech firms While staff retention was the primary difficulty for Digital and Technology companies in 2016, this has become secondary to the fastest emerging problem in 2017 – the lack and the cost of accommodation. According to the latest market analysis and salary survey by recruitment group Prosperity, the enduring reality is that the Digital and Tech [...]...
  • Private data exchange between businesses forecasted to be six times volume of public internet by 2020 – Equinix Equinix, Inc., the global Interconnection and data centre company, has announced that Bandwidth used in private data exchange between businesses is expected to be six times that of the public internet by 2020. The insights come from the Global Interconnection Index, a new market study published by Equinix. The Index found that Interconnection Bandwidth is outpacing growth of the public [...]...

BioMarin expands facility to manufacture medicine for rare genetic diseases

BioMarin expands facility to manufacture medicine for rare genetic diseases
July 31
09:00 2017

Simon Coveney, Minister for Foreign Affairs and Trade, has officially opened a new expansion at BioMarin Pharmaceutical Inc. in Shanbally, Co Cork. BioMarin has recently extended its site footprint to 20 acres as the company continues to experience a rise in the global demand for its therapies to treat rare genetic diseases that mostly affect children.

Since opening its doors in 2011, the company has grown to 365 employees in Cork, with an additional 67 people based in Dublin and 2,400 employees globally. BioMarin focuses on developing first-­‐in-­class and best-­in-­class therapeutics that have the potential to improve clinical outcomes of patients with rare genetic diseases. The company currently has six approved products that are the only drugs available on the market today for the diseases they treat.

This expansion project began two years ago to cater for continued growth at the site and includes an expanded warehouse, new administration and utilities offices, a canteen and conference facilities. The overall project will allow the company to maximise the flexibility of the site with the expansion of the operational manufacturing capacity. The site will also see the installation of a Waste Water Treatment Plant later this year, while three new lab expansions are to be completed by Q3 2018.

Jean-­Jacques Bienaimé, Chairman and Chief Executive Officer of BioMarin stated: “Ireland has proved to be an ideal location to expand our operations. The team at Shanbally has enabled us to accommodate our growing commercial portfolio and advancing clinical programs. Mostly children, our patients suffer from diseases so rare that the entire afflicted population may number as few as 1,000 worldwide. Often inherited, difficult to diagnose, and progressively debilitating, these conditions have, up until now, been largely ignored. As we continue to grow in Shanbally, we are looking to recruit the best and brightest in a variety of disciplines to help us continue our inspiring work for patients.”

Welcoming the expansion, Simon Coveney said: “Today’s announcement represents a significant investment in the local economy. Shanbally is BioMarin’s only manufacturing facility outside the US and what they have done in such a few short years is very impressive. The company is continuing to grow and I understand that there are up to 50 open positions across a variety of departments at Shanbally waiting to be filled. BioMarin is a prime example of the high-­‐tech Life Sciences companies that this area of Cork has a reputation for.”

CEO of IDA Ireland Martin Shanahan said: “I am delighted that BioMarin continues to consolidate its commitment to its Irish operations in Shanbally. The company’s presence in Cork strengthens Ireland’s global reputation as a biopharmaceutical industry leader and brings high quality jobs to countless people across the south-­west region. We look forward to working closely with the company as it further develops its operations here.”

About Author

editor

editor

Related Articles






Advertisements

































National Manufacturing Conference & Exhibition 2016

NIBRT Springboard Success Stories



Upcoming Events

  • No upcoming events
AEC v1.0.4

Join our Newsletter!



By subscribing you agree to receive updates from us by email. You can opt out of receiving emails at any time.